| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 10.524 | 13.080 | 21.893 | 128.280 | 158.896 | 354.536 | 238.003 | 4.658 | - | - |
| Total Income - EUR | 10.602 | 13.553 | 23.266 | 128.379 | 159.855 | 466.703 | 238.006 | 8.289 | - | - |
| Total Expenses - EUR | 7.648 | 8.341 | 12.652 | 126.675 | 155.520 | 309.393 | 78.805 | 54.247 | - | - |
| Gross Profit/Loss - EUR | 2.954 | 5.212 | 10.614 | 1.704 | 4.335 | 157.310 | 159.201 | -45.958 | - | - |
| Net Profit/Loss - EUR | 2.636 | 4.809 | 8.535 | 420 | 2.737 | 153.976 | 156.971 | -45.998 | - | - |
| Employees | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | - | - |
Check the financial reports for the company - Aryana Profarm Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 3.043 | 2.240 | 22.382 | 99.980 | 82.437 | 82.853 | - | - |
| Current Assets | 23.018 | 23.078 | 22.454 | 54.149 | 37.948 | 361.592 | 322.864 | 307.889 | - | - |
| Inventories | 2.514 | 1.940 | 1.607 | 1.401 | 10.790 | 124.863 | 105.674 | 123.850 | - | - |
| Receivables | 11.696 | 8.217 | 785 | 45.717 | 27.313 | 197.600 | 203.773 | 191.088 | - | - |
| Cash | 8.808 | 12.920 | 20.062 | 7.031 | -155 | 39.128 | 13.417 | -7.049 | - | - |
| Shareholders Funds | 1.024 | 3.380 | 11.858 | 12.046 | 14.564 | 154.431 | 185.621 | 140.199 | - | - |
| Social Capital | 225 | 223 | 219 | 215 | 211 | 413 | 404 | 406 | - | - |
| Debts | 21.925 | 19.698 | 13.572 | 44.278 | 45.701 | 307.128 | 219.697 | 250.559 | - | - |
| Income in Advance | 69 | 68 | 67 | 66 | 64 | 63 | 0 | 0 | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "4646 - 4646" | |||||||||
| CAEN Financial Year |
4646
|
|||||||||
Comments - Aryana Profarm Srl